Physiological Reports,
Год журнала:
2015,
Номер
3(9), С. e12558 - e12558
Опубликована: Сен. 1, 2015
Chronic
kidney
disease
(CKD)
is
associated
with
persistent
low-grade
inflammation
and
immunosuppression.
In
this
study
we
tested
the
role
of
Toll-like
receptor
4,
main
for
endotoxin
(LPS),
in
a
mouse
model
renal
fibrosis
progressive
CKD
that
better
resembles
human
disease.
C3HeJ
(TLR4
mutant)
mice
have
missense
point
mutation
TLR4
gene,
rendering
nonfunctional.
after
folic
acid
injection,
mutant
developed
less
interstititial
comparison
to
wild-type
(WT)
mice.
Furthermore,
4
weeks
5/6
nephrectomy
continuous
low-dose
angiotensin
II
infusion,
C3HeOuJ
WT)
albuminuria,
increased
serum
levels
BUN
creatinine,
glomerulosclerosis,
interstitial
fibrosis,
whereas
were
significantly
protected
from
progression.
WT
also
systemic
inflammation,
splenocyte
apoptosis
expression
immune
inhibitory
PD-1
spleen,
which
not
observed
vitro,
(LPS)
directly
upregulated
NLRP3
inflammasome
epithelial
cells
via
TLR4.
summary,
contributes
progression,
at
least
part,
activation
cells,
may
participate
dysregulated
response
CKD.
International Journal of Molecular Sciences,
Год журнала:
2021,
Номер
22(4), С. 1651 - 1651
Опубликована: Фев. 6, 2021
Diabetic
nephropathy
(DN)
is
a
common
pathological
feature
in
patients
with
diabetes
and
the
leading
cause
of
end-stage
renal
disease.
Although
several
pharmacological
agents
have
been
developed,
management
DN
remains
challenging.
Geniposide,
natural
compound
has
reported
for
anti-inflammatory
anti-diabetic
effects;
however,
its
role
poorly
understood.
This
study
investigated
protective
effects
geniposide
on
underlying
mechanisms.
We
used
C57BL/6
mouse
model
combination
high-fat
diet
streptozotocin
after
unilateral
nephrectomy
treated
by
oral
gavage
5
weeks.
Geniposide
effectively
improves
DN-induced
structural
functional
abnormalities
reducing
albuminuria,
podocyte
loss,
glomerular
tubular
injury,
inflammation
interstitial
fibrosis.
These
changes
induced
were
associated
an
increase
AMPK
activity
to
enhance
ULK1-mediated
autophagy
response
decrease
AKT
block
oxidative
stress,
fibrosis
diabetic
kidney.
In
addition,
increased
activities
PKA
GSK3β,
possibly
modulating
pathways,
efficiently
improving
dysfunction
ameliorating
progression
DN.
Conclusively,
enhances
reduces
fibrosis,
suggesting
as
promising
treatment
International Journal of Molecular Sciences,
Год журнала:
2022,
Номер
24(1), С. 570 - 570
Опубликована: Дек. 29, 2022
Diabetic
kidney
disease
(DKD)
is
the
leading
cause
of
chronic
disease,
including
end-stage
and
increases
risk
cardiovascular
mortality.
Although
treatment
options
for
DKD,
angiotensin-converting
enzyme
inhibitors,
angiotensin
II
receptor
blockers,
sodium-glucose
cotransporter
2
mineralocorticoid
antagonists,
have
advanced,
their
efficacy
still
limited.
Thus,
a
deeper
understanding
molecular
mechanisms
DKD
onset
progression
necessary
development
new
innovative
treatments
DKD.
The
complex
pathogenesis
includes
various
different
pathways,
can
be
broadly
classified
into
inflammatory,
fibrotic,
metabolic,
hemodynamic
factors.
Here,
we
summarize
recent
findings
in
basic
research,
focusing
on
each
factor
advances
Collective
evidence
from
clinical
research
studies
helpful
definitive
regulatory
systems.
Further
comprehensive
exploration
warranted
to
advance
our
knowledge
establish
novel
preventive
strategies.
Bioengineered,
Год журнала:
2022,
Номер
13(3), С. 7683 - 7696
Опубликована: Март 1, 2022
Diabetic
nephropathy
(DN)
is
a
common
complication
of
diabetes
mellitus
which
can
result
in
renal
failure
and
severely
affect
public
health.
Several
studies
have
revealed
the
important
role
podocyte
injury
DN
progression.
Although,
involvement
exosomes
derived
from
M2
macrophages
has
been
reported
injury,
underlying
molecular
mechanism
macrophage-secreted
not
fully
elucidated.
Our
study
suggests
that
mitigate
lipopolysaccharide
(LPS)-induced
podocytes
via
exosomes.
Moreover,
we
observed
miR-93-5p
expression
was
markedly
upregulated
macrophages.
Inhibition
macrophage
resulted
apoptosis
LPS-treated
podocytes.
Additionally,
TLR4
showed
potential
to
bind
miR-93-5p.
Subsequently,
validated
downstream
target
Further
findings
indicated
silencing
reversed
renoprotective
effects
miR-93-5p-containing
on
LPS-induced
injury.
In
summary,
our
demonstrated
attenuated
by
regulating
miR-93-5p/TLR4
axis,
provides
new
perspective
for
treatment
patients
with
DN.
Frontiers in Immunology,
Год журнала:
2024,
Номер
14
Опубликована: Янв. 15, 2024
The
glomerular
filtration
barrier,
comprising
the
inner
layer
of
capillary
fenestrated
endothelial
cells,
outermost
podocytes,
and
basement
membrane
between
them,
plays
a
pivotal
role
in
kidney
function.
Podocytes,
terminally
differentiated
epithelial
are
challenging
to
regenerate
once
injured.
They
essential
for
maintaining
integrity
barrier.
Damage
resulting
from
intrinsic
or
extrinsic
factors,
leads
proteinuria
early
stages
eventually
progresses
chronic
disease
(CKD).
Immune-mediated
podocyte
injury
is
primary
pathogenic
mechanism
proteinuric
diseases,
including
minimal
change
disease,
focal
segmental
glomerulosclerosis,
membranous
nephropathy,
lupus
nephritis
with
involvement.
An
extensive
body
evidence
indicates
that
podocytes
not
only
contribute
significantly
maintenance
barrier
serve
as
targets
immune
responses
but
also
exhibit
cell-like
characteristics,
participating
both
innate
adaptive
immunity.
play
mediating
represent
potential
therapeutic
CKD.
This
review
aims
systematically
elucidate
mechanisms
various
lesions
provide
an
overview
recent
advances
immunotherapy.
It
offers
valuable
insights
deeper
understanding
identification
new
targets,
has
significant
implications
future
clinical
diagnosis
treatment
podocyte-related
disorders.
Physiological Reports,
Год журнала:
2015,
Номер
3(9), С. e12558 - e12558
Опубликована: Сен. 1, 2015
Chronic
kidney
disease
(CKD)
is
associated
with
persistent
low-grade
inflammation
and
immunosuppression.
In
this
study
we
tested
the
role
of
Toll-like
receptor
4,
main
for
endotoxin
(LPS),
in
a
mouse
model
renal
fibrosis
progressive
CKD
that
better
resembles
human
disease.
C3HeJ
(TLR4
mutant)
mice
have
missense
point
mutation
TLR4
gene,
rendering
nonfunctional.
after
folic
acid
injection,
mutant
developed
less
interstititial
comparison
to
wild-type
(WT)
mice.
Furthermore,
4
weeks
5/6
nephrectomy
continuous
low-dose
angiotensin
II
infusion,
C3HeOuJ
WT)
albuminuria,
increased
serum
levels
BUN
creatinine,
glomerulosclerosis,
interstitial
fibrosis,
whereas
were
significantly
protected
from
progression.
WT
also
systemic
inflammation,
splenocyte
apoptosis
expression
immune
inhibitory
PD-1
spleen,
which
not
observed
vitro,
(LPS)
directly
upregulated
NLRP3
inflammasome
epithelial
cells
via
TLR4.
summary,
contributes
progression,
at
least
part,
activation
cells,
may
participate
dysregulated
response
CKD.